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Introduction
Neurofibromatosis type 1 (NF1) is an inherited autosomal-dominant condition 
and is known to affect every organ system. In NF1, mutation (in NF1 gene located 
in chromosome 17q11.2) causes loss of neurofibromin which increases the risk of 
developing benign and malignant tumours(1). We report a case of a young child 
who presented with painless loss of vision with NF1 and emphasize the role of 
regular ophthalmological assessment. 
Case Study
A 10-year-old boy presented to emergency department (ED) in a specialist hospital 
in north-eastern India with progressive painless dimness of vision in both eyes. 
Parents reported that that over the preceding 2 weeks he was finding it difficult 
to read and had deterioration in handwriting. He was repeatedly falling over and 
found it difficult to use the left side of his body. On arrival to the ED, observations 
were normal and Glasgow Coma Scale score was 15/15. Laboratory investigations 
were normal and his blood glucose was 86 mg/dl.
General examination revealed multiple café au lait spots, axillary freckling and a 
soft tissue swelling over right infratemporal region (which was a neurofibroma). 
Neurological examination revealed decreased power of 4/5 (Medical Research 
Council scale) in left side with exaggerated reflexes. Vision checked in ED 
revealed 6/20 on both eyes. The pubertal assessment showed Tanner stage 2 (testes 
volume 4 ml, few pigmented sparse pubic hairs) but parents were not aware when 
the pubertal changes actually started. A clinical diagnosis of NF1 was made and he 
was admitted for neurological observations which remained stable. 
Magnetic resonance imaging (MRI) scan of brain was organised to investigate a 
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A 10 year old presented with painless loss of vision as the first manifestation 
of neurofibromatosis 1 (NF1). Clinical assessment detected diagnostic features 
of NF1 and Magnetic Resonance Imaging (MRI) scan confirmed presence of 
plexiform neurofibroma and bilateral optic pathway glioma (OPG). The child 
was managed with chemotherapy which helped in improvement of vision. 
Review of current literature recommends vision testing in diagnosed cases of 
NP1 till 7 years of age; this is aimed at detecting visual impairments resulting 
from a symptomatic OPG.
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possible intracranial space-occupying lesion. The MRI 
scan revealed a large plexiform neurofibroma in the right 
infratemporal fossa, bilateral optic pathway gliomas 
(OPG), parasellar lesion originating from hypothalamic 
region and hamartomas (unidentified bright objects) in 
pineal region. Brain biopsy was refused by parents after 
detailed explanation. The non-availability of biopsy 
results rendered the diagnosis of brain lesions likely to 
be OPG but not definitive ones and was managed in 
light of the clinical context of NF1. He did not have any 
siblings and his parents refused physical examination for 
themselves.
Ophthalmology opinion was sought and the boy 
was transferred to the neurosurgeons. He underwent 
chemotherapy but parents did not agree for any surgical 
intervention. During the last follow-up his vision and left 
sided weakness had improved but has not completely 
normalized. He remains under care of the paediatric 
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Fig 1. Sagittal section of MRI brain scan shows large 
mass in optic chiasmatic region suggestive of optic 
pathway glioma with hamartomas.
Discussion 
This case highlights the importance of considering 
NF1 in a child presenting with painless loss of vision. 
In developing countries especially in rural or semi-
urban settings, health infrastructure is aimed more at 
treatment of pathologies. In the absence of screening 
and monitoring for conditions such as NF1, different 
associations with NF1 will often present to the ED in 
specialist centers like the child described. Cases where 
delayed diagnosis of NF1 is made, it is important to 
elicit signs of precocious puberty (predominantly central 
in origin) and can be associated with OPG (2).
OPGs occur in about 15% of children with NF1 and 
only 5% become symptomatic(1,3). A large number of 
OPGs remain asymptomatic for a long time before the 
manifestations caused by the tumours become evident: 
visual acuity loss, abnormal colour vision, visual field 
loss, squint, pupillary abnormalities, pale optic disc, 
proptosis and hypothalamic dysfunction(3). Young 
ch ldr n u der 7 years are at highest risk of developing 
OPGs(1) and are the most difficult age group to get an 
early diagnosis as they rarely complain of early visual 
impairment. The diagnosis of visual loss therefore 
remains difficult and is not often made until it becomes 
advanced with bilateral visual loss(3). Complete loss 
of vision due to OPG in children has been reported in 
the literature(4).
The big question that the clinician faces is whether it 
is possible to predict the vision loss when presented 
with OPG. A study of 26 children with OPG(5) 
which included 47 study eyes (normal vision= 31, 
abnormal vision= 16); decreased macular ganglion 
cell layer-inner plexiform layer thickness was found to 
discriminate between children with and without vision 
loss from their OPG. 
Age-appropriate annual ophthalmological assessments 
in NF1 are recommended till 7 years of age in the UK(6). 
The US committee on genetics recommends intensive 
Fig 2. Coronal MRI scans of brain showing right 
parasellar mass
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visual screening at 2, 4, 6, 9, 12, 15, 18, 24, 36, and 48 
months of age(7). Visual-evoked potential testing has 
been found to detect OPGs at an earlier stage but is not 
available for routine clinical use currently(7). 
In developing countries, specialist pediatric 
ophthalmology services are available only in specialist 
centers and it is important to explain to parents the 
importance of regular visual monitoring in children with 
NF1.   It is important to enquire about the child’s vision 
during assessment of children with NF1. Age-appropriate 
vision testing is recommended in all diagnosed cases of 
NF1 till the child reaches 7 years of age. 
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